6315-19-1 Usage
Uses
Used in Organic Synthesis:
6-Methylnaphthalene-1-carboxylic acid is used as a building block in the synthesis of various organic compounds due to its reactive functional groups and aromatic structure.
Used in Dye and Pigment Production:
6-Methylnaphthalene-1-carboxylic acid is used as a precursor in the production of dyes and pigments, leveraging its aromatic properties to impart color and stability to these products.
Used in Pharmaceutical Industry:
6-Methylnaphthalene-1-carboxylic acid is used as an intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs with potential therapeutic applications.
Used in Antimicrobial Applications:
6-Methylnaphthalene-1-carboxylic acid is studied for its potential use as an antimicrobial agent, with research exploring its ability to inhibit the growth of various microorganisms.
Used in Anti-Inflammatory Applications:
6-Methylnaphthalene-1-carboxylic acid is also being investigated for its potential as an anti-inflammatory agent, with the aim of developing new treatments for inflammatory conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 6315-19-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,1 and 5 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 6315-19:
(6*6)+(5*3)+(4*1)+(3*5)+(2*1)+(1*9)=81
81 % 10 = 1
So 6315-19-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H10O2/c1-8-5-6-10-9(7-8)3-2-4-11(10)12(13)14/h2-7H,1H3,(H,13,14)
6315-19-1Relevant academic research and scientific papers
THERAPEUTIC AGENTS FOR OCULAR HYPERTENSION
-
Paragraph 0076; 0100, (2015/07/02)
This invention provides well defined 6-alkyl or hydroxyalkyl-1-naphthamide or quinoline compounds for treating glaucoma or ocular hypertension.
THERAPEUTIC AGENTS FOR OCULAR HYPERTENSION
-
Page/Page column 25, (2012/01/15)
This invention provides well defined 6-alkyl or hydroxyalkyl-1-naphthamide or quinoline compounds for treating glaucoma or ocular hypertension.
The discovery and preparation of disubstituted novel amino-aryl-piperidine- based renin inhibitors
Cody, Wayne L.,Holsworth, Daniel D.,Powell, Noel A.,Jalaie, Mehran,Zhang, Erli,Wang, Wei,Samas, Brian,Bryant, John,Ostroski, Robert,Ryan, Michael J.,Edmunds, Jeremy J.
, p. 59 - 68 (2007/10/03)
Recently, trans-disubstituted oxo-aryl-piperidines have been identified as small molecule nonpeptide renin inhibitors for the modulation of hypertension. Herein, we report on the discovery and preparation of a new class of novel cis-disubstituted amino-aryl-piperidines as a mixture of enantiomers that are potent in vitro renin inhibitors and also, possess in vivo antihypertensive activity in a double transgenic mouse model.
